Limb-girdle
Showing 1 - 25 of 3,987
Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-9003)
Enrolling by invitation
- Limb Girdle Muscular Dystrophy
- SRP-9003
-
Columbus, OhioNationwide Children's Hospital
May 17, 2023
Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) Trial in Gainesville (BBP-418 (ribitol), Placebo)
Not yet recruiting
- Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
- BBP-418 (ribitol)
- Placebo
-
Gainesville, FloridaUniversity of Florida
Mar 16, 2023
Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-6004)
Enrolling by invitation
- Limb Girdle Muscular Dystrophy
- SRP-6004
-
Columbus, OhioNationwide Children's Hospital
Jun 7, 2023
Trial Readiness and Endpoint Assessment in LGMD R1
Not yet recruiting
- Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
- +3 more
-
Richmond, VirginiaVirginia Commonwealth University
Jan 10, 2023
Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED) Trial in Charlotte
Completed
- Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)
-
Charlotte, North CarolinaCarolinas Medical Center - Pediatrics
Apr 20, 2022
Motor Parameters in Patients With Limb Girdle Muscular Dystrophy
Recruiting
- Limb Girdle Muscular Dystrophies
-
Garche, FranceLaboratoire d'analyse du mouvement, Service d'exploration foncti
May 2, 2022
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
Recruiting
- Limb Girdle Muscular Dystrophy
- No intervention
-
Copenhagen, DenmarkNanna Scharff Poulsen
Jan 17, 2023
Limb-Girdle Muscular Dystrophy, Type 2E Trial in Columbus (SRP-9003)
Active, not recruiting
- Limb-Girdle Muscular Dystrophy, Type 2E
- SRP-9003
-
Columbus, OhioNationwide Children's Hospital
Sep 28, 2022
Identification of Dominant Calpainopathies
Enrolling by invitation
- Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
- retrospective study
-
Venice-Lido, VE, Italy
- +1 more
Jul 19, 2023
Muscular Dystrophies, Spinal Muscular Atrophy, Duchenne Muscular Dystrophy Trial in Saint Paul (Abilitech Assist)
Recruiting
- Muscular Dystrophies
- +6 more
- Abilitech Assist
-
Saint Paul, MinnesotaGillette Children's
Dec 1, 2022
Dysferlinopathy, Miyoshi Myopathy, LGMDR2 Trial in Moscow
Enrolling by invitation
- Dysferlinopathy
- +3 more
-
Moscow, Russian FederationHuman Stem Cells Institute
Jul 25, 2022
LGMD2C Trial (ATA-200)
Not yet recruiting
- LGMD2C
- ATA-200
- (no location specified)
Aug 1, 2023
Limb Girdle Muscular Dystrophy Type 2A and Type 2E
Recruiting
- Limb-Girdle Muscular Dystrophy Type 2A
- Limb-Girdle Muscular Dystrophy, Type 2E
-
Columbus, OhioNationwide Children's Hospital
Dec 6, 2021
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level
Not yet recruiting
- Limb Girdle Muscular Dystrophy
- +8 more
- LION-101 dose level 1
- +2 more
- (no location specified)
Feb 17, 2022
Patients With Limb Girdle Muscular Distrophy Type 2E
Completed
- LGMD2E
- Exon 3 truncating mutation
- Any other mutation in SGBC gene
-
Milano, ItalyIRCCS Ca' Granda Ospedale Maggiore Policlinico
Mar 29, 2022
Patients With Limb-Girdle Muscular Dystrophy 2I
Active, not recruiting
- LGMD2I
-
Copenhagen, Denmark
- +2 more
Jan 4, 2022
Limb-Girdle Muscular Dystrophy Type 2I in Norway
Recruiting
- Limb Girdle Muscular Dystrophy, Type 2I
- +3 more
-
Tromsø, NorwayNational Neuromuscular Centre, Norway
Sep 9, 2021
Limb-Girdle Muscular Dystrophy Trial in Worldwide (Deflazacort)
Terminated
- Limb-Girdle Muscular Dystrophy
-
Atlanta, Georgia
- +17 more
May 31, 2022
Limb-girdle Muscular Dystrophy, Becker Muscular Dystrophy Trial in Chicago (Prednisone)
Active, not recruiting
- Limb-girdle Muscular Dystrophy
- Becker Muscular Dystrophy
-
Chicago, IllinoisNorthwestern University
Jan 8, 2022
Assess Exercise-induced Muscle Damage in Muscle Diseases
Enrolling by invitation
- Becker Muscular Dystrophy
- +2 more
-
Copenhagen, DenmarkNeuromuscular Research Unit, 3342
Dec 17, 2021
LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, = 4 Years of Age, Who Are
Recruiting
- Limb-girdle Muscular Dystrophy
-
Phoenix, Arizona
- +14 more
Aug 23, 2022
3 Year Follow up on ANO5 Patients
Active, not recruiting
- Neuromuscular Diseases
- Limb Girdle Muscular Dystrophy
- No intervention - pure observational study
-
Copenhagen, Region Hovedstaden, DenmarkCopenhagen Neuromuscular Center
Jan 25, 2022
LGMDR9 Trial in Copenhagen, Paris, Newcastle Upon Tyne (GNT0006, Day 0: Placebo, Day 0: GNT0006)
Recruiting
- LGMDR9
- GNT0006
- +4 more
-
Copenhagen, Denmark
- +2 more
Oct 21, 2022
LGMD Trial (GenPHSat injection (Safety), GenPHSat injection (Efficacy), Muscle Biopsy (Safety))
Not yet recruiting
- LGMD
- GenPHSat injection (Safety)
- +2 more
- (no location specified)
Oct 20, 2022
LGMD2I Trial in Richmond (BBP-418)
Active, not recruiting
- LGMD2I
-
Richmond, VirginiaVirginia Commonwealth University
Dec 17, 2021